NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 3 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,535 | -2.7% | 311,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $59,152 | -51.9% | 311,000 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $123,000 | -62.4% | 311,000 | 0.0% | 0.00% | -55.6% |
| Q2 2022 | $327,000 | -44.1% | 311,000 | 0.0% | 0.01% | -47.1% |
| Q1 2022 | $585,000 | -33.1% | 311,000 | 0.0% | 0.02% | -22.7% |
| Q4 2021 | $874,000 | -22.2% | 311,000 | 0.0% | 0.02% | -24.1% |
| Q3 2021 | $1,123,000 | -24.6% | 311,000 | 0.0% | 0.03% | -34.1% |
| Q2 2021 | $1,490,000 | -35.2% | 311,000 | 0.0% | 0.04% | -25.4% |
| Q1 2021 | $2,298,000 | +5.7% | 311,000 | 0.0% | 0.06% | +7.3% |
| Q4 2020 | $2,174,000 | – | 311,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |